Home » Topics » Regulatory

Regulatory
RSS

CP-122638: Pfizer's potential treatment for non-migraine emesis

July 26, 1996

5-HT3/NK1 antagonist combination effective in emesis treatment and prevention

July 26, 1996

Chinoin describes new selegiline formulation

July 26, 1996

Raloxifene indicated for excess NPY associated disorders

July 26, 1996

Duloxetine claimed for new indication

July 26, 1996

Fujisawa claims tacrolimus as allergic conjunctivitus treatment

July 26, 1996

Ciclosporin demonstrates efficacy and safety as an antimetabolite

July 26, 1996

InSite Vision and Bausch & Lomb announce alliance regarding glaucoma drug

July 26, 1996

New formulation of CGP-41251

July 26, 1996

IL-2/interferon alpha/5-FU combination effective against metastatic renal cancer

July 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Aug. 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Aug. 15, 2025.
NME Digest: Q2 2025
BioWorld
A quarterly dynamic table featuring new molecular entities (NMEs) revealed for the first time in current literature, at congresses and in company communications...
Merck’s MK-2214 shows potential to slow Alzheimer’s pathology
BioWorld Science
Abnormal tau aggregation is a hallmark of Alzheimer’s disease (AD) and a major contributor to neurodegeneration, synaptic dysfunction, and progressive functional...
Scemblix ticks Novartis earnings box; more ahead in CML
BioWorld
Novartis AG’s financial update included good news about Scemblix (asciminib), the first and only U.S. FDA-approved allosteric inhibitor for chronic myeloid...